Development of 4-sulfated N -acetyl galactosamine anchored chitosan nanoparticles: A dual strategy for effective management of Leishmaniasis
- 1 December 2015
- journal article
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 136, 150-159
Abstract
No abstract availableKeywords
Funding Information
- CSIR
This publication has 39 references indexed in Scilit:
- Leishmania donovani Triose Phosphate Isomerase: A Potential Vaccine Target against Visceral LeishmaniasisPLOS ONE, 2012
- Development of nanocapsules bearing doxorubicin for macrophage targeting through the phosphatidylserine ligand: a system for intervention in visceral leishmaniasisJournal of Antimicrobial Chemotherapy, 2012
- Investigations into an alternate approach to target mannose receptors on macrophages using 4-sulfated N-acetyl galactosamine more efficiently in comparison with mannose-decorated liposomes: an application in drug deliveryNanomedicine: Nanotechnology, Biology and Medicine, 2012
- The mechanisms of drug release in poly(lactic-co-glycolic acid)-based drug delivery systems—A reviewInternational Journal of Pharmaceutics, 2011
- Chitosan-based macrophage-mediated drug targeting for the treatment of experimental visceral leishmaniasisJournal of Microencapsulation, 2011
- Amphotericin B inhibits entry of Leishmania donovani into primary macrophagesBiochemical and Biophysical Research Communications, 2010
- Mannosylated nanoparticulate carriers of rifabutin for alveolar targetingJournal of Drug Targeting, 2009
- Amphotericin B Formulations and Drug TargetingJournal of Pharmaceutical Sciences, 2008
- Biodegradable nanoparticles for cytosolic delivery of therapeutics☆Advanced Drug Delivery Reviews, 2007
- Receptor-mediated stimulatory effect of oligochitosan in macrophagesBiochemical and Biophysical Research Communications, 2004